{
  "id": "extra_chemo_001",
  "type": "pattern",
  "content": "Chemotherapy Encounter: Z51.11 (ICD-10) / V58.11 (ICD-9) codes indicate patient is admitted primarily for administration of chemotherapy. This is NOT a diagnosis but an encounter code. Clinical context: Patient has underlying malignancy (check for cancer diagnosis in PMH or concurrent diagnoses). Chemotherapy agents administered during this visit are diagnostic clues (cisplatin, carboplatin, 5-FU, doxorubicin, etc.). Complications to monitor: febrile neutropenia (fever + ANC<500), nausea/vomiting, mucositis, diarrhea, cytopenias, tumor lysis syndrome, cardiotoxicity, nephrotoxicity. Common concurrent diagnoses: cancer type (breast, lung, colon, lymphoma, etc.), anemia, thrombocytopenia, neutropenia, dehydration, electrolyte abnormalities. Lab surveillance: CBC, CMP, tumor markers. Supportive care: anti-emetics, growth factors (G-CSF), hydration, prophylactic antibiotics if neutropenic.",
  "metadata": {
    "category": "oncology",
    "diagnosis": "chemotherapy_encounter",
    "priority": "MODERATE",
    "icd9_codes": ["V5811"],
    "icd10_codes": ["Z5111"]
  },
  "created_at": "2025-11-10T00:00:00",
  "name": "Chemotherapy Encounter - Clinical Context"
}
